1Melki JR, Clark SJ. DNA methylation changes in leukaemia. Semin Cancer Biol, 2002,12:347-357.
2Drexler HG. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes plS, p16, p18 and p19 in human leukemia-lymphoma cells. Leukemia, 1998,12:845-859.
3Takasaki Y, Yamada Y, Sugahara K, et al. Interruption of p16 gene expression in adult T-cell leukaemia/lymphoma: clinical correlation.Br J Haematol, 2003,122:253-259.
4Herman JG, Graff JR, Myohanen S, et al. Methylation-specific PCR:a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A, 1996,93:9821-9826.
5Schmittgen TD, Zakrajsek BA, Mills AG, et al. Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods. Anal Biochem, 2000,285:194-204.
6Wang KK, Liu N, Radulovich N, et al. Novel candidate tumor marker genes for lung adenocarcinoma. Oncogene, 2002,21:7598-7604.
8Hartwell LH, Kastan MB. Cell cycle control and cancer. Science, 1994,266 : 1821-1828.
9Coqueret O. Linking cyclins to transcriptional control. Gene, 2002,299:35-55.
10Ogawa S,Hangasishi A,Miyawaki S, et al. Loss of the cyclin-dependent kinase 4-inhibitor ( P16 ; MTS1 ) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies. Blood, 1995, 86:1548-1556.
